Your browser doesn't support javascript.
loading
IDegLira Improves Metabolic Control in Patients with Type 2 Diabetes Previously Treated with Premix Insulin.
Bostandzic, Amela Dizdarevic; Beslic, Vanja Karlovic; Surkovic, Ismana; Balic, Sefkija; Dujic, Tanja; Asimi, Zelija Velija; Burekovic, Azra.
Afiliación
  • Bostandzic AD; Clinic for Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Beslic VK; Clinic for Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Surkovic I; Clinic for Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Balic S; Clinic for Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Dujic T; Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Asimi ZV; Medical School Sarajevo, Department of Internal Medicine, SSST University in Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Burekovic A; Clinic for Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Med Arch ; 76(2): 96-100, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35774039
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: Med Arch Año: 2022 Tipo del documento: Article Pais de publicación: Bosnia-Herzegovina
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: Med Arch Año: 2022 Tipo del documento: Article Pais de publicación: Bosnia-Herzegovina